Health

NHS faces shortage of painkillers, steroids and anti-depressants as drug supply problems worsen

NHS faces shortage of painkillers, steroids and anti-depressants as drug supply problems worsen, consultants warn

  • Companies face ‘unprecedented pressure’ with supply chains and pink tape
  • Manufacturers scuffling with ‘perfect storm’ of rising prices of uncooked supplies 
  • Mark Samuels mentioned there was a ‘real risk’ the NHS will face additional shortages

The NHS is dealing with shortages of blood strain capsules, painkillers and anti-depressants as drug producers are hit by supply problems, an business physique has warned.

Companies offering broadly used drugs face ‘unprecedented pressure’ with supply chains and pink tape, it’s claimed.

Manufacturers of dozens of the UK’s mostly used medication are scuffling with a ‘perfect storm’ of rising prices of uncooked supplies and delays of as much as 18 months to safe approvals from the medicines regulator.

Some anti-depressants, blood strain tablets, steroids and capsules used to alleviate arthritis ache might be affected, in response to the i newspaper.

The NHS is facing shortages of blood pressure pills, painkillers and anti-depressants as drug producers are hit by supply problems, an industry body has warned (stock image)

The NHS is dealing with shortages of blood strain capsules, painkillers and anti-depressants as drug producers are hit by supply problems, an business physique has warned (stock picture)

British Generic Manufacturers Association chief govt Mark Samuels mentioned there was a ‘real risk’ the NHS and pharmacies will face additional shortages within the coming months – much like the present HRT disaster.

‘Generic medicines have been taken for granted,’ Mr Samuels mentioned.

‘It is a complex industry and it is under unprecedented pressure and that does bring a real risk of shortages at the moment.’

The UK regulator – the Medicines and Healthcare merchandise Regulatory Agency – mentioned it frequently accelerates approval processes the place a product might be the topic of a shortage.

British Generic Manufacturers Association chief executive Mark Samuels said there was a ‘real risk’ the NHS and pharmacies will face further shortages in the coming months – similar to the current HRT crisis (stock image)

British Generic Manufacturers Association chief govt Mark Samuels mentioned there was a ‘real risk’ the NHS and pharmacies will face additional shortages within the coming months – much like the present HRT disaster (stock picture)

Figures point out there are almost 50 generic medicines provided to the NHS in a selected dimension or energy which can be listed as having supply points – a 25 per cent enhance within the final month.

Of these, 44 haven’t any equal various.

A supply at one of the UK’s main generic producers mentioned there are ‘very fine margins’ in a drug being viable to provide or not.

Separate figures from the Pharmaceutical Services Negotiating Committee, which represents 11,000 NHS pharmacy contractors, confirmed 67 medication have been listed in March as drugs for which the Government was prepared to pay the next value as a consequence of problems such as supply points.

Another business physique, the Association of Independent Multiple Pharmacies, mentioned the quantity of sufferers dealing with points with acquiring drugs is prone to be no less than 500,000.

Advertisement

Back to top button